Sugi Predict

Sugi Predict / Compounds / SCHEMBL19909516

SCHEMBL19909516

SCHEMBL19909516

Cc1cc(-c2cc(-n3c4ccccc4c4ccc(C#N)cc43)c(C#N)cc2-n2c3ccccc3c3ccc(C#N)cc32)cc(C)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 2/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TDP2 O95551 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ GRM5 P41594 2/20 0.33
▸ MAT2A P31153 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33
▸ IMPDH2 P12268 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19919629 0.95 CYP11B2 (0.35) PTGER4CA1CA2CYP1A2CYP2C9
SCHEMBL19909334 0.93 PTGER4 (0.35) PTGER4CA1CA2CYP1A2CYP2C9
SCHEMBL22170441 0.92 CHEK1 (0.37) PTGER4CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19919756 0.92 STS (0.35) PTGER4CYP11B1CYP11B2ADORA2A
SCHEMBL19919714 0.91 ADORA2A (0.37) CYP1A2CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL19913217 0.90 KDM4E (0.36) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL22170397 0.90 KDM4E (0.36) CYP1A2CYP2C9CYP2C19NPSR1KDM4E
SCHEMBL19909094 0.89 IRAK4 (0.32) PTGER4CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL22563701 0.89 ABCG2 (0.36) PTGER4CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL19913222 0.89 ALDH1A1 (0.36) CYP1A2CYP2C9CYP2C19NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 — — US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 — — US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 — — US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 PTGER4 1123/4885CA1 1885/4885CA2 1268/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 PTGER4 1386/4885CA1 1384/4885CA2 814/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 PTGER4 1123/4885CA1 1885/4885CA2 1268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.